-+ 0.00%
-+ 0.00%
-+ 0.00%

Anixa to present ovarian cancer CAR-T trial update at ISCT annual meeting

PUBT·04/22/2026 12:45:27
Listen to the news
Anixa to present ovarian cancer CAR-T trial update at ISCT annual meeting
  • Anixa Biosciences to present Phase 1 data update for ovarian cancer CAR-T candidate lira-cel at ISCT 2026 Annual Meeting on May 6-9, 2026, in Dublin.
  • Presentation covers trial design, objectives, current status for lira-cel in recurrent ovarian cancer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anixa Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202604220845PR_NEWS_USPR_____LA40467) on April 22, 2026, and is solely responsible for the information contained therein.